Artículo completo (castellano) Extensión:  +/-6.33 páginas impresas en papel A4 Exclusivo para suscriptores/assinantes

Pharmaceutical Assistance in Brazil: An Overview

Abstract
Brazil is a developing country whose healthcare system is still being implemented and, therefore, pharmaceutical assistance exerts a significant impact upon its healthcare system. In this context, this study discusses the main issues related to pharmaceutical assistance in Brazil, to then establish the major challenges that still need to be overcome. Over the last few decades, the pharmaceutical sector in Brazil has been going through many changes. In fact, the first National Drug Policy was published in 1998 and the National Health Vigilance Agency created in 1999, followed by the National Pharmaceutical Assistance Policy publication in 2004. Consequently, regulation mechanisms were improved and intensified. In addition, pharmaceutical assistance actions were restructured via a decentralization of resources and actions of the counties and states. In the public sector, however, problems are still observed related to the general public's access to essential drugs, as well as in management and service quality. Furthermore, drug commercialization and practices within the private sector need to be regulated. Procedures to promote rational drug use among healthcare professionals and users should also be implemented.

Key words
pharmaceutical assistance, rational drug use, drug policy, essential drugs, pharmacy

Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.

Suscripción a siicsalud